ArticleIrish journal of medical science2025
Investigation of the association between MSR1 serum levels and type 2 diabetes: a preliminary study.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Supernatant of Water Extraction-Ethanol Precipitation ofFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by peripheral insulin resistance and impaired insulin secretion. It is prevalent worldwide including in Turkey and is a major contributor to metabolic and inflammatory complications. Macrophage Scavenger Receptor 1 (MSR1), a class A scavenger receptor (SR-A1), is primarily expressed in macrophages and plays a significant role in the immune response. MSR1 has been implicated in the pathogenesis of metabolic diseases, yet its precise role in glucose metabolism remains unclear, despite reports suggesting a correlation between its transcript levels and insulin sensitivity.
aimsThis study aimed to evaluate the association between serum MSR1 levels and insulin resistance in patients with T2DM and to investigate its potential as a therapeutic target.
methodsThe study included 40 patients with T2DM and 40 healthy volunteers. Blood samples were collected and sera were separated by centrifugation and stored at -80 °C. MSR1 serum levels were measured using a commercial ELISA kit (NE010338901) and absorbance was read at 450 nm. Statistical analysis was performed using IBM SPSS Statistics 21.
resultsMSR1 levels were higher in the diabetic group than in controls; however, the difference was not statistically significant (p = 0.897).
conclusionsThe findings suggest a potential association between MSR1 and T2DM. Although the difference was not statistically significant, the observed trend supports the need for further studies with larger sample sizes to clarify the potential role and clinical relevance of MSR1 as a biomarker or therapeutic target.
Indexed as
Identifiers
40762936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.